Paper146160
Circulating immune complexes in the idiopathic interstitial pneumonias.
Dreisin RB and 3 others. N Engl J Med, 1978. Cited by 283 papers, by iCite.
Cite this record
ConductScience Library. Circulating immune complexes in the idiopathic interstitial pneumonias. Papers, record 146160. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/146160
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigen-Antibody Complex | Major topic |
| Pulmonary Fibrosis | Major topic |
| Adrenal Cortex Hormones | |
| Complement C3 | |
| Humans | |
| Immune Complex Diseases | |
| Immunoglobulin A | |
| Immunoglobulin G | |
| Immunoglobulin M | |
| Lung |
Source PubMed
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 283 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40309766 | Complement's involvement in allergic Th2 immunity: a cross-barrier perspective. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40309766 | PubMed |
| 37214353 | Overview on the Link Between the Complement System and Auto-Immune Articular and Pulmonary Disease. | Open Access Rheumatol | 2023 | https://conductscience.org/library/papers/37214353 | PubMed |
| 35901283 | Our Compliments to the Authors: Decay Accelerating Factor and the Complement System in Pulmonary Fibrosis. | Am J Respir Cell Mol Biol | 2022 | https://conductscience.org/library/papers/35901283 | PubMed |
| 35895592 | Overexpression of Decay Accelerating Factor Mitigates Fibrotic Responses to Lung Injury. | Am J Respir Cell Mol Biol | 2022 | https://conductscience.org/library/papers/35895592 | PubMed |
| 34813613 | Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations. | PLoS One | 2021 | https://conductscience.org/library/papers/34813613 | PubMed |
| 32385381 | Label-free plasma proteomics identifies haptoglobin-related protein as candidate marker of idiopathic pulmonary fibrosis and dysregulation of complement and oxidative pathways. | Sci Rep | 2020 | https://conductscience.org/library/papers/32385381 | PubMed |
| 29565179 | The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis. | Am J Physiol Lung Cell Mol Physiol | 2018 | https://conductscience.org/library/papers/29565179 | PubMed |
| 29377033 | Potential Mechanisms Underlying TGF-β-mediated Complement Activation in Lung Fibrosis. | Cell Mol Med Open Access | 2017 | https://conductscience.org/library/papers/29377033 | PubMed |
| 28654764 | Deep Proteome Profiling Reveals Common Prevalence of MZB1-Positive Plasma B Cells in Human Lung and Skin Fibrosis. | Am J Respir Crit Care Med | 2017 | https://conductscience.org/library/papers/28654764 | PubMed |
| 26956419 | Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis. | FASEB J | 2016 | https://conductscience.org/library/papers/26956419 | PubMed |
| 26337158 | Complement inhibition decreases early fibrogenic events in the lung of septic baboons. | J Cell Mol Med | 2015 | https://conductscience.org/library/papers/26337158 | PubMed |
| 24958208 | Crosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis. | FASEB J | 2014 | https://conductscience.org/library/papers/24958208 | PubMed |
| 24901241 | Complement system in lung disease. | Am J Respir Cell Mol Biol | 2014 | https://conductscience.org/library/papers/24901241 | PubMed |
| 22584870 | Idiopathic pulmonary fibrosis is associated with circulating antiepithelial antibodies. | Lung | 2012 | https://conductscience.org/library/papers/22584870 | PubMed |
| 22287715 | MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I. | J Immunol | 2012 | https://conductscience.org/library/papers/22287715 | PubMed |
| 20929558 | Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression. | BMC Pulm Med | 2010 | https://conductscience.org/library/papers/20929558 | PubMed |
| 20924590 | Fcγ receptor IIIb (CD16b) polymorphisms are associated with susceptibility to idiopathic pulmonary fibrosis. | Lung | 2010 | https://conductscience.org/library/papers/20924590 | PubMed |
| 17847114 | IgM, IgG, and IgA rheumatoid factors in pigeon hypersensitivity pneumonitis. | J Clin Lab Anal | 2007 | https://conductscience.org/library/papers/17847114 | PubMed |
| 11686865 | Autoantibodies in cryptogenic fibrosing alveolitis. | Respir Res | 2001 | https://conductscience.org/library/papers/11686865 | PubMed |
| 11050267 | Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. | Thorax | 2000 | https://conductscience.org/library/papers/11050267 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/146160
GET https://conductscience.org/api/papers/v1/146160/cited_by?page=2